Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Brookstone Capital Management trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.9% in the fourth ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

Patients are reporting difficulties accessing the anti-COVID drug Paxlovid this winter, even as the coronavirus causing the infectious disease reaches levels not seen in months. Angela Carpio couldn’t ...

Pfizer (NYSE:PFE – Get Free Report) had its price objective lowered by analysts at UBS Group from $31.00 to $29.00 in a ...

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid ...

A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...

Pfizer's stock has plummeted due to declining ... However, in 2024 COVID-19 products together (Comirnaty and anti-viral Paxlovid) are expected to contribute only 16-17% to total sales (about ...

The Biden administration’s bird flu response has been too slow. Now comes a test for Trump’s White House.